AI assistant
Sending…
Akari Therapeutics Plc — Director's Dealing 2016
Jun 30, 2016
34762_dirs_2016-06-30_f3ba6394-db09-44f4-ad2b-3d234a8264df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Akari Therapeutics Plc (AKTX)
CIK: 0001541157
Period of Report: 2016-06-29
Reporting Person: Williams Donald Allen (Director)
More from Akari Therapeutics Plc
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 19
Capital/Financing Update
2026
May 8
Annual Report
2026
Mar 30
Capital/Financing Update
2026
Mar 17
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 2
Proxy Solicitation & Information Statement
2026
Feb 2
Capital/Financing Update
2026
Jan 23
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19